Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

Obstructive sleep apnea affects the quality of life of millions of people, but current solutions are not always well accepted. A recent clinical trial could change the game by proposing a ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep — they stop breathing sometimes 20 to 50 to 100 times a night and are abruptly awakened.

Supplements may negatively affect sleep quality due to their ingredients, mode of action, or the timing of doses. Some vitamins, such as melatonin, promote relaxation and induce sleep. Others can act ...

People struggling with insomnia tend to hyperfocus on the fact that they can't sleep, which can prevent them from getting any ...